Merus N.V. Made Headway

Thu, Oct 07, 2021 at 05:33 PM

Merus N.V. (MRUS:NASDAQ) soared at $27.49, representing a gain of 37.5%. On Wed, Oct 06, 2021, MRUS:NASDAQ hit a New 2-Week Low of $20. The stock appeared on our News Catalysts scanner on Thu, Oct 07, 2021 at 10:35 AM in the 'BIOTECH' category. From Wed, Sep 22, 2021, the stock recorded 30.00% Up Days and 27.27% Green Days

The share price of the company has been moving sideways in recent weeks.

About Merus N.V. (MRUS:NASDAQ)

Merus BV is a clinical stage immuno-oncology company. It is engaged in developing bispecific antibody therapeutics.

Top 10 Gainers:

Camber Energy, Inc. (CEI:NYSEMKT), 95.93%
Merus N.V. (MRUS:NASDAQ), 37.45%
New Fortress Energy LLC (NFE:NASDAQ), 25.51%
Aehr Test Systems (AEHR:NASDAQ), 22.41%
PEDEVCO Corp. (PED:NYSEMKT), 21.47%
BRCN (BRCN:NASDAQ), 20.44%
TKNO (TKNO:NASDAQ), 20.08%
Altisource Portfolio Solutions S.A. (ASPS:NASDAQ), 18.33%
Bicycle Therapeutics plc (BCYC:NASDAQ), 16.76%
Q&K International Group Limited (QK:NASDAQ), 16.68%